Skip to content
akaturk Academic measurement
2025 SJR Q3 JCR Q4 · 1,5 OA 8 matched articles ESCI

Journal detail

ecancermedicalscience

Publisher
ecancer Global Foundation
Country
United Kingdom · Western Europe
Type
journal
ISSN
  • 17546605
Scopus 0,503 SJR
Scopus Q3 SJR Q
WoS Q4 JCR Q
WoS 1,5 JIF
Scopus 54 H-Index

Integrated evaluation

Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.

WoS / JCR data covers 1997 onward.

Scopus

Scopus · Scimago

  • SJR 0,503
  • Quartile Q3
  • H-Index 54
  • Cites/doc 1,49
  • Docs (3y) 485
  • Cites (3y) 813

Clarivate

Web of Science · JCR · 2025

  • JCR Q Q4
  • JIF 1,5
  • 5Y JIF 1,7
  • JCI 0,28

WoS indexes

  • ESCI

Subject classification

Yearly quartile comparison

Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.

WoS / JCR data covers 1997 onward.

Note: JCR Q, JIF, 5Y JIF, JCI, and JCI Q are blank before 1997 — WoS/JCR data on this site starts in 1997.
Year SJR Q JCR Q (1997+) SJR JIF (1997+) 5Y JIF (1997+) JCI (1997+) JCI Q (1997+) H-Index
2025 Q3 Q4 0,503 1,5 1,7 0,28 Q4 54
2024 Q3 Q4 0,54 1,3 1,8 0,26 Q4 51
2023 Q3 Q4 0,515 1,2 1,9 0,36 Q4 51
2022 Q3 — 0,665 1,8 2,3 0,46 Q3 51
2021 Q3 — 0,665 — — 0,63 Q3 51
2020 Q3 — 0,708 — — 0,43 Q4 51
2019 Q3 — 0,572 — — — — 51
2017 Q3 — 0,688 — — — — 51
2016 Q3 — 0,54 — — — — 51
2015 Q3 — 0,43 — — — — 51
2014 Q3 — 0,258 — — — — 51
2013 Q3 — 0,272 — — — — 51
2012 Q3 — 0,154 — — — — 51
2011 Q4 — 0,106 — — — — 51
2010 Q4 — 0,102 — — — — 51

JCR category quartile history

JCR / JCI quartile by year and category. 1997 and later.

WoS / JCR data covers 1997 onward.

Note: This table shows Clarivate category quartile records from 1997 onward.
Year Category Edition JCR Q (1997+) JCI Q (1997+) Rank
2025 ONCOLOGY ESCI Q4 Q4 284/333
2024 ONCOLOGY ESCI Q4 Q4 275/328
2023 ONCOLOGY ESCI Q4 Q4 273/322
2022 ONCOLOGY ESCI — Q3 —
2021 ONCOLOGY ESCI — Q3 —
2020 ONCOLOGY ESCI — Q4 —